Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Colorectal Neoplasms 119Carcinoma, Hepatocellular 69Ovarian Neoplasms 62Neoplasms 36Carcinoma, Non-Small-Cell Lung 34Fallopian Tube Neoplasms 29Brain Neoplasms 24Glioblastoma 22Colonic Neoplasms 21Breast Neoplasms 19Neoplasm Metastasis 18Endometrial Neoplasms 18Stomach Neoplasms 15Uterine Cervical Neoplasms 14Rectal Neoplasms 14Lung Neoplasms 14Liver Neoplasms 11Triple Negative Breast Neoplasms 10Melanoma 8Glioma 8Carcinoma, Renal Cell 8Carcinoma, Ovarian Epithelial 8Biliary Tract Neoplasms 8Colorectal Cancer Metastatic 7Squamous Cell Carcinoma of Head and Neck 6Recurrence 6Parkinson Disease 4, Autosomal Dominant Lewy Body 6Gastrointestinal Neoplasms 6Advanced Solid Tumors 6Small Cell Lung Carcinoma 5

Interventions

pembrolizumab 6Cetuximab 5olaparib 3atezolizumab 3Injections 3fludarabine 2Trastuzumab 2Docetaxel 2Cyclophosphamide 2Bevacizumab 2zimberelimab 1zansecimab 1tocilizumab 1taxane 1spartalizumab 1somatostatin receptor 2 1ribociclib 1pralsetinib 1pertuzumab 1pegylated granulocyte colony-stimulating factor 1lenvatinib 1ipatasertib 1inavolisib 1fludarabine phosphate 1entrectinib 1encorafenib 1durvalumab 1dapagliflozin 1cemiplimab 1brigimadlin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solid Tumors × Bevacizumab × 1 year × Clear all
NCT05101070 2026-03-18

aCCeleR8-001

Shionogi Inc.

Phase 1/2 Recruiting
282 enrolled
Other solid neoplasm

Solid Tumors

NCT05836324 2025-12-18

A Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

Incyte Corporation

Phase 1 Recruiting
408 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡